Colgate-Palmolive (NYSE:CL) posted its quarterly earnings data on Friday. The company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.05, MarketWatch Earnings reports. The firm had revenue of $3.90 billion during the quarter, compared to analysts’ expectations of $3.78 billion. Colgate-Palmolive had a net margin of 15.86% and a return on equity of 942.99%. Colgate-Palmolive’s revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.72 EPS.

Shares of Colgate-Palmolive stock opened at $77.20 on Friday. The stock’s fifty day simple moving average is $73.69 and its 200 day simple moving average is $71.47. The company has a current ratio of 0.96, a quick ratio of 0.66 and a debt-to-equity ratio of 21.51. The company has a market capitalization of $66.12 billion, a PE ratio of 26.35, a PEG ratio of 4.76 and a beta of 0.60. Colgate-Palmolive has a 12 month low of $58.49 and a 12 month high of $77.46.

The company also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be issued a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 2.28%. The ex-dividend date of this dividend is Friday, July 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is 62.19%.

CL has been the subject of a number of recent research reports. Morgan Stanley downgraded Colgate-Palmolive from an “overweight” rating to an “equal weight” rating and set a $78.00 target price for the company. in a research report on Wednesday, July 22nd. They noted that the move was a valuation call. Stifel Nicolaus upped their target price on shares of Colgate-Palmolive from $72.00 to $75.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Royal Bank of Canada reaffirmed a “buy” rating and issued a $88.00 target price on shares of Colgate-Palmolive in a research note on Thursday. Credit Suisse Group reissued a “sell” rating and set a $67.00 price target on shares of Colgate-Palmolive in a research note on Monday, May 4th. Finally, TheStreet cut shares of Colgate-Palmolive from a “b” rating to a “c+” rating in a research note on Friday, May 1st. Three research analysts have rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $74.92.

In other Colgate-Palmolive news, Director Michael B. Polk sold 3,115 shares of the business’s stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $68.08, for a total value of $212,069.20. Following the completion of the transaction, the director now directly owns 20,622 shares of the company’s stock, valued at $1,403,945.76. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.78% of the stock is currently owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Story: How is a buy-side analyst different from a sell-side analyst?

Earnings History for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with's FREE daily email newsletter.